Viewing Study NCT01838434

Home Icon Home Search Icon Search Certify Doc Icon Certify Doc Certify Doc Icon Genes Certify Doc Icon Clinical Trials Certify Doc Icon CompTox Processes Icon DrugMatrix Open Targets Icon Open Targets Processes Icon Products Support Icon Support Bugs Icon Bugs
Main Search Make This Study a Gene Therapy Make This Study a Not Gene Therapy Report Bug
Ignite Creation Date: 2025-12-25 @ 2:23 AM
Ignite Modification Date: 2026-03-06 @ 12:32 PM
Study NCT ID: NCT01838434
Status: COMPLETED
Last Update Posted: 2018-01-30
First Post: 2013-04-19
Is Gene Therapy: True
Has Adverse Events: False
Brief Title: Lenalidomide With or Without Idelalisib in Treating Patients With Relapsed or Refractory Mantle Cell Lymphoma
Sponsor: Alliance for Clinical Trials in Oncology
Organization:
Overview Dates Organization Conditions Design Enrollment Locations Outcomes Modules Raw JSON

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Relapsed/Refractory Mantle Cell Lymphoma View
Keywords: